Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 148 | 135 | 154 | 157 | 177 | 166 | 187 | 193 | 217 | 196 | 224 | 240 |
| Expenses | 110 | 103 | 121 | 115 | 129 | 124 | 130 | 135 | 145 | 138 | 149 | 163 |
| Operating Profit | 38 | 32 | 34 | 42 | 48 | 42 | 57 | 58 | 71 | 58 | 75 | 77 |
| OPM % | 25% | 23% | 22% | 27% | 27% | 25% | 30% | 30% | 33% | 30% | 34% | 32% |
| Other Income | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 5 | 3 | -1 | 5 | 5 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 2 | 1 |
| Depreciation | 11 | 13 | 13 | 11 | 13 | 17 | 14 | 11 | 12 | 22 | 14 | 12 |
| Profit before tax | 28 | 20 | 23 | 34 | 37 | 28 | 47 | 50 | 63 | 35 | 64 | 68 |
| Tax % | 28% | 26% | 25% | 29% | 28% | 32% | 54% | 24% | 24% | 21% | 24% | 25% |
| Net Profit | 20 | 15 | 17 | 24 | 26 | 19 | 22 | 38 | 48 | 28 | 49 | 51 |
| EPS in Rs | 1.28 | 0.97 | 1.12 | 1.52 | 1.68 | 1.20 | 1.36 | 2.45 | 3.02 | 1.82 | 2.96 | 3.28 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 304 | 356 | 403 | 434 | 495 | 589 | 527 | 572 | 687 | 829 | 876 |
| Expenses | 147 | 189 | 212 | 249 | 261 | 323 | 353 | 403 | 432 | 498 | 566 | 594 |
| Operating Profit | 94 | 115 | 145 | 154 | 174 | 171 | 236 | 123 | 140 | 190 | 263 | 282 |
| OPM % | 39% | 38% | 41% | 38% | 40% | 35% | 40% | 23% | 24% | 28% | 32% | 32% |
| Other Income | 7 | -15 | 21 | 11 | 1 | 12 | 29 | 9 | 9 | 15 | 12 | 12 |
| Interest | 1 | 0 | 0 | 1 | 2 | 1 | 3 | 5 | 6 | 4 | 4 | 3 |
| Depreciation | 18 | 18 | 20 | 26 | 32 | 30 | 34 | 39 | 47 | 55 | 59 | 60 |
| Profit before tax | 82 | 82 | 145 | 138 | 140 | 152 | 228 | 89 | 96 | 145 | 213 | 231 |
| Tax % | 37% | 48% | 36% | 38% | 37% | 26% | 23% | 27% | 28% | 38% | 24% | |
| Net Profit | 52 | 43 | 93 | 85 | 88 | 113 | 176 | 64 | 69 | 91 | 163 | 176 |
| EPS in Rs | 3.21 | 2.66 | 5.79 | 5.38 | 5.58 | 7.13 | 11.10 | 4.06 | 4.45 | 5.76 | 10.24 | 11.08 |
| Dividend Payout % | 104% | 125% | 58% | 124% | 30% | 117% | 45% | 148% | 135% | 122% | 137% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 13% | 11% | 16% | 21% | ||
| Compounded Profit Growth | 12% | 8% | 36% | 70% | ||
| Stock Price CAGR | 10% | 7% | 42% | 41% | ||
| Return on Equity | 21% | 20% | 20% | 28% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 54 | 54 | 54 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 159 |
| Reserves | 226 | 312 | 354 | 390 | 382 | 314 | 374 | 474 | 481 | 474 | 494 | 426 |
| Borrowings | 0 | 0 | 0 | 0 | 2 | 12 | 8 | 21 | 23 | 42 | 25 | 51 |
| Other Liabilities | 53 | 44 | 30 | 36 | 37 | 90 | 106 | 60 | 74 | 75 | 121 | 111 |
| Total Liabilities | 329 | 410 | 438 | 479 | 475 | 469 | 541 | 607 | 632 | 644 | 693 | 747 |
| Fixed Assets | 196 | 259 | 259 | 299 | 294 | 269 | 253 | 285 | 294 | 306 | 297 | 317 |
| CWIP | 6 | 1 | 17 | 0 | 1 | 5 | 8 | 3 | 2 | 3 | 14 | 3 |
| Investments | 86 | 93 | 104 | 120 | 95 | 90 | 126 | 146 | 144 | 162 | 162 | 177 |
| Other Assets | 42 | 56 | 58 | 60 | 84 | 105 | 154 | 173 | 192 | 173 | 220 | 250 |
| Total Assets | 329 | 410 | 438 | 479 | 475 | 469 | 541 | 607 | 632 | 644 | 693 | 747 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 34 | 68 | 90 | 107 | 100 | 168 | 115 | 113 | 129 | 168 | 191 | 213 |
| Cash from Investing Activity | -18 | -18 | -42 | -43 | -12 | 1 | -49 | -24 | -39 | -91 | -53 | -23 |
| Cash from Financing Activity | -23 | -45 | -49 | -64 | -94 | -165 | -62 | -89 | -86 | -85 | -130 | -170 |
| Net Cash Flow | -6 | 5 | -0 | -0 | -5 | 4 | 4 | 0 | 4 | -8 | 8 | 21 |
| Free Cash Flow | 25 | 53 | 53 | 63 | 61 | 158 | 93 | 99 | 88 | 107 | 146 | 198 |
| CFO/OP | 79% | 106% | 113% | 108% | 104% | 122% | 92% | 72% | 128% | 141% | 123% | 104% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 11 | 8 | 10 | 11 | 14 | 33 | 58 | 59 | 28 | 39 | 33 |
| Inventory Days | 48 | 56 | 65 | 66 | 60 | 64 | 52 | 53 | 62 | 104 | 89 | 81 |
| Days Payable | 5 | 10 | 6 | 25 | 25 | 68 | 56 | 36 | 54 | 88 | 146 | 109 |
| Cash Conversion Cycle | 53 | 57 | 67 | 50 | 46 | 10 | 29 | 75 | 67 | 44 | -18 | 4 |
| Working Capital Days | 28 | 2 | 19 | 10 | 28 | -8 | 19 | 41 | 31 | 7 | 13 | 19 |
| ROCE % | 24% | 28% | 33% | 30% | 35% | 36% | 42% | 17% | 18% | 25% | 35% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.14% | 71.11% | 71.11% | 71.11% | 71.11% | 71.06% | 71.06% | 71.06% | 71.06% | 60.93% | 60.92% | 60.92% |
| FIIs | 3.46% | 3.35% | 2.90% | 2.49% | 1.93% | 2.77% | 2.41% | 3.23% | 4.85% | 4.96% | 5.37% | 5.43% |
| DIIs | 13.33% | 13.89% | 14.88% | 14.89% | 14.79% | 14.68% | 14.97% | 14.54% | 13.47% | 20.52% | 21.00% | 20.92% |
| Public | 12.08% | 11.64% | 11.11% | 11.49% | 12.15% | 11.49% | 11.57% | 11.18% | 10.61% | 13.61% | 12.71% | 12.71% |
| No. of Shareholders | 72,000 | 68,844 | 64,823 | 61,636 | 59,377 | 56,666 | 57,403 | 54,566 | 54,142 | 77,619 | 73,377 | 73,064 |
Fundamentals
Market Cap₹ 8,708 Cr.
Current Price₹ 547
Stock P/E48.2
Book Value₹ 36.8
ROCE35.4 %
ROE28.4 %
Dividend Yield1.71 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)21%
Compounded Profit Growth (TTM)70%
Consolidated figures.
Valuation
Market capRs 8,493 Cr
Enterprise valueRs 8,476 Cr
P/E (TTM)48.17x
Price to book14.51x
Price to sales9.69x
EV / EBITDA28.86x
EV / EBIT36.21x
EV / sales9.68x
Price to cash flow39.83x
Earnings yield2.08%
Dividend yield2.62%
P/E, 3-year average20.65x
P/B, 3-year average4.56x
P/E, 5-year average16.30x
P/B, 5-year average3.54x
Profitability
Operating margin (excl. other income)31.75%
Operating margin (incl. other income)33.22%
EBITDA margin33.53%
Pre-tax margin26.33%
Net profit margin20.13%
Net margin, latest quarter21.74%
ROE28.80%
ROCE35.91%
ROA22.64%
ROE, 3-year average19.73%
ROCE, 3-year average26.70%
ROA, 3-year average15.81%
ROE, 5-year average21.66%
ROCE, 5-year average28.80%
ROA, 5-year average17.70%
ROIC (approx.)31.52%
Tax rate23.50%
Other income / net worth2.09%
Growth
Sales growth (latest year)20.61%
Profit growth (latest year)78.17%
Sales CAGR, 3 years16.33%
Sales CAGR, 5 years10.88%
Profit CAGR, 3 years36.23%
Profit CAGR, 5 years7.58%
Sales growth QoQ7.18%
Profit growth QoQ10.76%
Sales growth YoY (latest quarter)24.34%
Profit growth YoY (latest quarter)34.06%
Per share
EPS (TTM)Rs 11.08
EPS (latest year)Rs 10.24
EPS (latest quarter)Rs 3.28
EPS, 3-year averageRs 13.62
EPS, 5-year averageRs 17.27
Book value per shareRs 36.79
Sales per shareRs 55.04
Cash flow per shareRs 13.40
Free cash flow per shareRs 12.44
Dividend per share (latest year)Rs 14.00
Dividend per share, 3-year averageRs 17.67
Dividend per share, 5-year averageRs 17.20
Dividends
Dividend payout136.68%
Dividend payout, 3-year average130.99%
Dividend payout, 5-year average117.15%
Efficiency
Asset turnover1.11x
Fixed asset turnover2.61x
Inventory turnover6.77x
Inventory days54 days
Debtor days33 days
Debtors turnover11.22x
Creditor days109 days
Cash conversion cycle4 days
Working capital days19 days
Leverage
Total debtRs 51 Cr
Cash and bankRs 68 Cr
Net debtRs -17 Cr
Debt to equity0.09x
Net debt / EBITDA-0.06x
Interest coverage69.45x
Current ratio (filing 2026-03-31)3.39x
Quick ratio (filing 2026-03-31)2.95x
Trade payables (filing 2026-03-31)Rs 65 Cr
Owners' fund to total sources78.36%
Debt to assets6.78%
Cash flow
Cash from Operating Activity (latest year)Rs 213 Cr
Cash from Investing Activity (latest year)Rs -23 Cr
Cash from Financing Activity (latest year)Rs -170 Cr
Net Cash Flow (latest year)Rs 21 Cr
Free cash flow (latest year)Rs 198 Cr
FCFE (approx.: FCF + change in debt)Rs 224 Cr
Cash from ops / profit, 5 years1.45x
Sales to cash flow3.89x
Statement figures
Net sales (TTM)Rs 876 Cr
Net sales (latest year)Rs 829 Cr
Sales (latest quarter)Rs 240 Cr
Operating profit excl. other income (latest year)Rs 263 Cr
Operating profit (latest quarter)Rs 77 Cr
Other income (TTM)Rs 12 Cr
EBITDA (TTM)Rs 294 Cr
PBDT (TTM)Rs 290 Cr
Profit before tax (TTM)Rs 231 Cr
Tax (latest year)Rs 50 Cr
Net profit (TTM)Rs 176 Cr
Net profit (latest year)Rs 163 Cr
Net profit (latest quarter)Rs 52 Cr
Depreciation (TTM)Rs 60 Cr
Depreciation (latest quarter)Rs 12 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 328 Cr
Total expenditure (latest year)Rs 566 Cr
Total income (latest year)Rs 841 Cr
Share capitalRs 159 Cr
ReservesRs 426 Cr
Shareholders' fundsRs 586 Cr
Total assetsRs 747 Cr
Net blockRs 317 Cr
Capital work in progressRs 3 Cr
InvestmentsRs 177 Cr
ReceivablesRs 74 Cr
InventoryRs 48 Cr
Other liabilitiesRs 111 Cr
Shares outstanding (crore)15.92
Ownership
Promoter holding60.92% (-10.14 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 48.2 is at the 50th percentile of its own 9.4-year range
(median 48.2, low 12.9, high 90.1).
P/B 14.51 is at the 88th percentile (median 8.18).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | THYROCARE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -5.8% | -2.8% | -3.1 pts |
| 1 month | -9.6% | -6.8% | -2.9 pts |
| 3 months | -4.0% | -7.6% | +3.7 pts |
| 6 months | +52.7% | +0.4% | +52.2 pts |
| 1 year | +33.5% | -9.9% | +43.4 pts |
| 2 years | +92.4% | -13.6% | +106.0 pts |
| 3 years | +181.7% | +14.2% | +167.5 pts |
| 5 years | +38.5% | +27.9% | +10.6 pts |
48 mutual fund schemes hold about ₹2,208 Cr.
Over three months 31 bought more and 12 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| HSBC Midcap Fund | 1.99% | 342 | +33% |
| Nippon India Small Cap Fund | 0.38% | 312 | +9% |
| Aditya Birla SL ELSS Tax Saver Fund | 1.66% | 242 | +36% |
| Nippon India Pharma Fund | 2.45% | 232 | -4% |
| ICICI Pru Dividend Yield Fund | 1.91% | 128 | +12% |
| HSBC Large & Mid Cap Fund | 1.77% | 105 | +3% |
| HSBC Small Cap Fund | 0.49% | 93 | +100% |
| ICICI Pru Healthcare Fund- | 1.30% | 91 | -40% |
| DSP Healthcare Fund | 2.11% | 81 | +100% |
| ICICI Pru Innovation Fund | 0.75% | 59 | -36% |
| HSBC Aggressive Hybrid Fund | 1.00% | 59 | +100% |
| HSBC Multi Cap Fund | 0.84% | 51 | +100% |
| ICICI Pru Equity Savings Fund(Q | 0.31% | 51 | +100% |
| HDFC Pharma and Healthcare Fund | 1.31% | 43 | -10% |
| Aditya Birla SL Business Cycle Fund | 2.31% | 43 | +8% |
| HDFC Innovation Fund | 1.27% | 41 | -6% |
| ICICI Pru Active Momentum Fund | 1.31% | 28 | +10% |
| Bank of India Small Cap Fund | 0.84% | 28 | +100% |
| WOC Flexi Cap Fund | 0.29% | 27 | +100% |
| Aditya Birla SL Pharma & Healthcare Fund | 1.94% | 21 | +5% |
| WOC Pharma and Healthcare Fund | 2.31% | 21 | +15% |
| WOC Special Opp Fund | 0.97% | 19 | +100% |
| Aditya Birla SL Bal Bhavishya Yojna | 1.43% | 18 | +17% |
| WOC Multi Cap Fund | 0.34% | 14 | +100% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.39% | 10 | +7% |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹240 Cr +24.4% vs Jun 2025.
Net profit ₹51 Cr +34.2%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
| Star Imaging and Path Lab Ltd | 131 | 6.80 | 26.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-06-23 | Dividend - Rs 7 Per Share | |
| 2025-11-28 | Bonus 2:1 | 0.3333 |
| 2025-10-24 | Interim Dividend - Rs 7 Per Share | |
| 2025-07-25 | Dividend - Rs 21 Per Share | |
| 2024-08-16 | Dividend - Rs 18 Per Share | |
| 2023-04-20 | Interim Dividend - Rs 18 Per Share | |
| 2022-07-25 | Annual General Meeting | |
| 2022-05-11 | Interim Dividend - Rs 15 Per Share | |
| 2021-06-17 | Annual General Meeting/Dividend - Rs 15 Per Share | |
| 2020-11-12 | Interim Dividend - Rs 10 Per Share | |
| 2019-11-21 | Interim Dividend - Rs 5 Per Share | |
| 2019-08-14 | Dividend - Rs 20 Per Share | |
| 2018-08-02 | Annual General Meeting/Dividend- Rs 5 Per Share | |
| 2018-02-15 | Interim Dividend Rs 5/- Per Share | |
| 2017-08-03 | Annual General Meeting/Dividend - Rs 5/- Per Share | |
| 2017-02-08 | Interim Dividend Rs 5/- Per Share (Purpose Revised) | |
| 2016-09-01 | Annual General Meeting/Dividend - Rs 2.50 Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
The Overall encumbered share in the scrip is more than 50 Percent.
Quick answers
What is the market cap of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd (THYROCARE) has a market capitalisation of Rs 8,708 Cr. at the 2026-10-01 close.
What is the P/E ratio of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd trades at a P/E of 48.2 on trailing twelve-month profit, at the 2026-10-01 close.
What were Thyrocare Technologies Ltd's latest quarterly results?
In the Jun 2026 quarter, Thyrocare Technologies Ltd sales was Rs 240 Cr (+24.4% vs Jun 2025) and net profit was Rs 51 Cr.
What is the 52-week high and low of Thyrocare Technologies Ltd?
The 52-week high is Rs 662.00 and the 52-week low is Rs 342.55.